The content on our site is not intended as medical advice or to replace information from a qualified healthcare professional.
Additionally, growing awareness of early diagnosis, preventive care, and lifestyle modification programs are being actively promoted by public health groups and health authorities is indirectly increasing demand for GLP-1based therapies
A meta-analysis including 4,121 patients with MACS or non-functioning adrenal incidentalomas reported a diabetes prevalence of 28.1% in MACS compared with 14.4% in non-functioning tumours [176]
Strengths and limitations To the best of our knowledge, this study is the first systematic review and meta-analysis to assess the MACE and hospitalization for heart failure outcomes of SGLT-2i and GLP-1RA combination therapy and its metabolic and safety outcomes
3 min read Big news for those watching the GLP-1 race: A new pill just dropped
Rosenstock J, Guerci B, Hanefeld M, et al
